Many people, especially those who are overweight or obese, live with obsessive or intrusive thoughts about food and eating
This decision means that compounding pharmacies must wind down production of essential copies of commercial semaglutide: By April 22, 2025, for traditional, state-licensed pharmacies (503A pharmacies) By May 22, 2025, for federally registered outsourcing facilities (503B outsourcing facilities) Does the FDA ruling mean I wont be able to access semaglutide anymore
Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth
It is contraindicated in pregnancy and breastfeeding, can cause significant irritation, and increases photosensitivity
Simple strategies, such as slower dose escalation or dietary adjustments, can make a meaningful difference